Section 1369.654 - Prohibition On Multiple Prior Authorizations(a) A health benefit plan issuer that provides prescription drug benefits may not require an enrollee to receive more than one prior authorization annually of the prescription drug benefit for a prescription drug prescribed to treat an autoimmune disease, hemophilia, or Von Willebrand disease. (b) This section does not apply to: (1) opioids, benzodiazepines, barbiturates, or carisoprodol; (2) prescription drugs that have a typical treatment period of less than 12 months; (3) drugs that: (A) have a boxed warning assigned by the United States Food and Drug Administration for use; and (B) must have specific provider assessment; or (4) the use of a drug approved for use by the United States Food and Drug Administration in a manner other than the approved use. Tex. Ins. Code § 1369.654
Added by Acts 2023, Texas Acts of the 88th Leg.- Regular Session, ch. 669,Sec. 1, eff. 9/1/2023, app. only to a health benefit plan that is delivered, issued for delivery, or renewed on or after January 1, 2024.